Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total parenteral support (PS) necessary for them to survive Groundbreaking PS ...

And even well-insured patients receive unaffordable bills in this era of high-deductible health plans, narrow insurance networks, and 20% cost sharing.

As health care companies grow larger, so are patient costs but federal regulators have been slow to confront the issue during the Trump administration. A cancer patient might live in a town with four ...

Health Minister Mussab al-Ali met Sunday with Arab Confederation for Physical Therapy President Sida Sassin and her ...

Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...